This brief highlights the benefits of applying implementation science early in clinical development rather than waiting until post-launch. It explains how early contextual analysis, impact planning, and preparatory actions can reduce deployment risk and improve real-world adoption of new therapies or practices. By engaging stakeholders early and integrating implementation insights alongside clinical evidence generation, organizations can optimize launch readiness, close care gaps, and improve sustainability. IQVIA emphasizes that starting early increases the likelihood of successful uptake, maximized patient benefit, and long-term value realization across healthcare systems.

Join for free to read